elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q27693249-E7A0FD12-0FB6-49C3-AEA3-CAED560B34E7
Q27693249-E7A0FD12-0FB6-49C3-AEA3-CAED560B34E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27693249-E7A0FD12-0FB6-49C3-AEA3-CAED560B34E7
Review of daclizumab and its therapeutic potential in the treatment of relapsing-remitting multiple sclerosis
P2860
Q27693249-E7A0FD12-0FB6-49C3-AEA3-CAED560B34E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27693249-E7A0FD12-0FB6-49C3-AEA3-CAED560B34E7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b1cf0fc4e2d1fc5fd92b64162530561db924b2a4
P2860
Inhibition of LTi cell development by CD25 blockade is associated with decreased intrathecal inflammation in multiple sclerosis.